10-102230720-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_005029.4(PITX3):c.703G>A(p.Val235Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00021 in 1,540,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005029.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PITX3 | NM_005029.4 | c.703G>A | p.Val235Met | missense_variant | 4/4 | ENST00000370002.8 | NP_005020.1 | |
PITX3 | XM_047425352.1 | c.703G>A | p.Val235Met | missense_variant | 3/3 | XP_047281308.1 | ||
GBF1 | NM_001391923.1 | c.-207C>T | 5_prime_UTR_variant | 1/40 | NP_001378852.1 | |||
GBF1 | NM_001391924.1 | c.-345C>T | 5_prime_UTR_variant | 1/41 | NP_001378853.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PITX3 | ENST00000370002.8 | c.703G>A | p.Val235Met | missense_variant | 4/4 | 1 | NM_005029.4 | ENSP00000359019 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 151772Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000101 AC: 14AN: 138408Hom.: 0 AF XY: 0.0000538 AC XY: 4AN XY: 74404
GnomAD4 exome AF: 0.000208 AC: 289AN: 1388838Hom.: 0 Cov.: 32 AF XY: 0.000194 AC XY: 133AN XY: 684890
GnomAD4 genome AF: 0.000224 AC: 34AN: 151880Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74250
ClinVar
Submissions by phenotype
PITX3-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 09, 2023 | The PITX3 c.703G>A variant is predicted to result in the amino acid substitution p.Val235Met. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.028% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/10-103990477-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 24, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with PITX3-related conditions. This variant is present in population databases (rs148445461, gnomAD 0.03%). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 235 of the PITX3 protein (p.Val235Met). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at